Sub-group variable | Sub-group category (L = Low or H = High) | N per sub group | Intervention arm | Standard care arm | Intervention- Control (SE)* | Difference (H-L) (95% C.I.) | P interaction |
---|---|---|---|---|---|---|---|
HbA1c % (mmol/mol) | 7.5 – 7.9 (58-63) | 85 | 80.4 (24.5) | 62.6 (34.2) | 17.7 (6.4) | ||
8.0 - 12.4 (64-112) | 108 | 74.8 (27.7) | 72.8 (27.8) | 2.0 (5.3) | -15.8 (-32.9, 1.2) | 0.07 | |
Age (years) | 37 – 64 | 94 | 75.0 (25.61) | 72.3 (27.3) | 2.7 (5.6) | ||
65 and over | 100 | 80.0 (27.1) | 66.4 (33.2) | 13.5 (6.0) | 10.8 (-5.4, 27.2) | 0.19 | |
Total number of medications | 0 – 5 | 89 | 80.2 (23.3) | 73.0 (27.0) | 7.2 (5.3) | ||
6 and over | 105 | 75.1 (28.5) | 65 .2 (33.7) | 10.0 (6.1) | 2.8 (-13.5, 19.1) | 0.74 | |
Self reported adherence at baseline | 0-23 | 102 | 75.0 (26.4) | 70.9 (27.2) | 4.1 (5.5) | ||
24 or 25 | 70 | 85.9 (21.3) | 68.0 (33.9) | 17.9 (6.8) | 13.8 (-3.2, 30.0) | 0.11 | |
Prior randomisation to medication monitoring device | No | 102 | 76.6 (28.7) | 71.0 (29.3) | 5.6 (5.8) | ||
Yes | 92 | 78.2 (23.7) | 66.65 (32.6) | 11.6 (5.9) | 6.0 (-10.5, 22.7) | 0.48 | |
Gender | Male | 127 | 77.0 (28.3) | 66.4 (31.5) | 10.6 (5.3) | ||
Female | 67 | 78.0 (22.9) | 74.8 (28.8) | 3.3 (6.4) | -7.3 (-24.3, 9.6) | 0.39 |